trial

Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia Patients

NCTId NCT07541157
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 80 (actual)
Sponsored by Hasanuddin University
Primary completion 2026-01-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
80 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2025-09-01
Primary completion
2026-01-31
Eligibility
MALE · 20 Years · 45 Years

Interventions & indications

Drugs
RisperidoneAshwagandha

Sponsors

Hasanuddin UniversityLead Sponsor

Investigators

1
Rina Nurul Qalbi, MDPrincipal Investigator

Sites

1 total
Makassar, Indonesia

Facts & assertions

4 sourced
Enrollment
80
Phase
NA
Primary Completion Date
2026-01-31
Status
COMPLETED
relationships
The graph out of here
drug
Risperidone
drug
Ashwagandha
drug
lead_sponsor
Hasanuddin University
company
indication
Schizophrenia Patients
indication
investigator
Rina Nurul Qalbi, MD
person